BioSpace News Archive

Sanford Health, the largest provider of rural healthcare in the country, today announced an $800,000 investment in TruGenomix, a veteran-owned precision behavioral health company. As part of the strategic partnership, Sanford Health will support Tru

Apricorn, the leading manufacturer of software-free, 256-bit AES XTS hardware-encrypted USB 3.2 storage devices, has launched the Aegis Secure Key 3NXC – the first device of its kind with a USB-C connector

Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2020 second quarter earnings investor webcast on Tues

RAD Technology Medical Systems (RAD) is pleased to announce the completion of their most recent project, a standalone Crisis Stabilization Unit (CSU) for Palomar Health. Construction of the facility was completed in June 2020 and as of July 2, 2020 the facility was treating patients.

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on July 30, 2020 at 4:30 p.m. ET to review its second quarter 2020 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the Investors/Media section of Infinity’s website at www.infi.com . To participate in the conference call, please dial (877) 316-5293 (domestic) and (631) 291-45

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the second quarter after market close on Wednesday, August 5, 2020. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT. Investors int

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the Company is actively working on the development of therapies for patients infected wi

Qualtrics, the leader in customer experience and creator of the experience management (XM) category, today announced it is an approved vendor for the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. Hospitals can now view their HCAHPS results alongside their real-time data in the Qualtrics XM Platform™,

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced it has acquired 10% of Bloodbuy (BloodSolutions, LLC), a cloud-based marketplace that facilitates buying and selling of blood components in the U.S.

Company Reaches Consensus with FDA on Key Aspects of Novel Pivotal Phase 3 Study Agency Guidance May Provide Significant Time- and Cost-Efficiency for Phase 3 Program Approximately 17 Million American Adults Suffer from Social Anxiety Disorder [23-July-2020]